opioid

How health execs can partner with pharmacists to address opioidsDirector of medication safety and quality for the American Society of Health-System Pharmacists shares how providers can better work with pharmacists to address the opioid epidemic.
FDA: Opioid Cold Meds Not Safe for Kids
FDA: Opioid Cold Meds Not Safe for KidsThe agency’s ruling also added an additional Boxed Warning.
To curb opioid abuse, new technologies must be embraced
To curb opioid abuse, new technologies must be embracedThe opioid epidemic is exacting a lethal toll on the country. We must redouble and accelerate efforts to slow—and hopefully reverse—the current opioid epidemic.
Four health programs successfully fight the opioid epidemicShocking opioid overdose statistics make it crucial to address the epidemic. Here are four programs to watch
Four PBM programs poised to rein in the opioid epidemicPBMs are in a unique position to help curb opioid abuse. Here are four programs that demonstrate promising outcomes.
Top 10 Drug Topics Web Articles of 2017
Top 10 Drug Topics Web Articles of 2017Our 10 best articles, based on the number of views.
FDA: New assessment discourages morcellation for fibroidsAn updated review of evidence by the US Food and Drug Administration (FDA) underscores concerns expressed in 2014 by the agency about use of laparoscopic power morcellators (LPM) for treatment of uterine fibroids. Plus: Prescription habits show ob/gyns not well informed about opioids, according to a study. Also: Does ADHD medication use during pregnancy increase risk of congenital malformations?
Healthcare leaders must step up to fix the opioid epidemicHealthcare executives have a unique leadership role to play in addressing the opioid crisis. Here’s what you need to do now.
Kentucky opioid program drops dispensing by 50%Howard Shaps, MD, senior medical director, WellCare of Kentucky, shares details about the Medicaid insurers’ pilot program designed to fight the opioid epidemic.
The role of ophthalmologists in the opioid epidemicAn observational cohort study, published in JAMA Ophthalmology, used Medicare Part D data to assess the number of opioid prescriptions written by ophthalmologists in the United States.